S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Pulsed Dye Laser (PDL) Therapy in Adults

Completed · Phase 3 · Has a placebo group

Conditions studied: Pain

In brief

Pulsed dye laser (PDL) on the face is painful. For this reason, local anesthesia is commonly used to eliminate or minimize the pain. S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) is a eutectic formulation of lidocaine and tetracaine. The purpose of this study is to evaluate the efficacy of S-Caine Peel for induction of local dermal anesthesia for PDL therapy in adults.

Key facts

Study ID

NCT00110773

Run by

ZARS Pharma Inc.

People needed

80

Starts

2005-06-01

Expected to finish

2005-10-01

Last updated by the study team

2012-06-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is 18 years of age or older
• Patient elects to undergo PDL therapy for the treatment of vascular lesions on the face

You may not qualify if…

• Patient is pregnant or breastfeeding
• Patient has participated in a clinical trial of an unapproved drug within the previous 30 days
• Patient has participated in any clinical trial involving S-Caine Peel

Where it is running

• Washington Institute of Dermatologic Laser Surgery — Washington D.C., District of Columbia, United States
• Midwest Cutaneous Research — Clinton Township, Michigan, United States
• Laser and Skin Surgery Center of New York — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.